Klaus Edvardsen's Location
Denmark
Klaus Edvardsen's Work
- Chief Development Officer @ Vaccibody AS
- Chief DevelopmentOfficer/Chief Medical Officer @ CureVac
- Senior Vice President, Global Head Oncology Development @ Merck Group
- Senior Vice President , Head Global Medicines Development Oncology @ AstraZeneca
- Vice President - Head Clinical Developement Oncology @ AstraZeneca
- Vice President - Medicines Development Leader - Arzerra/ofatumumab @ GSK
- Vice President - Therapeutic Area Clinical Lead - Oncology @ GSK
- Phycisian Project Leader - Arzerra (ofatumumab) @ GSK
- VP, Clinical/Medical Project and Portfolio Management @ Genmab
Klaus Edvardsen's Education
- Københavns Universitet
Doctor Of Philosophy (Medicine)
1982 - 1990
Klaus Edvardsen's Skills
- Clinical Development
- Cancer Research
- Oncology
- Cell Biology
- Translational Research
- CRO
- Clinical Trials
- Cancer
- Clinical Research
- Commercialization
Klaus Edvardsen's Summary
Klaus Edvardsen, based in Denmark, is currently a Chief Development Officer at Nykode Therapeutics, bringing experience from previous roles at CureVac, Merck Group and AstraZeneca. Klaus Edvardsen holds a 1982 - 1990 Doctor Of Philosophy in Medicine @ Københavns Universitet. With a robust skill set that includes Clinical Development, Cancer Research, Oncology, Cell Biology, Translational Research and more, Klaus Edvardsen contributes valuable insights to the industry. Klaus Edvardsen has 4 emails on RocketReach.
5 free lookups per month.
No credit card required.
If you need more lookups,
subscriptions start at $48 USD/month.
Not the Klaus Edvardsen you were looking for?
Find contact details for 700 million professionals.
People Like Klaus Edvardsen
-
35+
-
52
-
ViewHeather Braun
Director Value and Access, Global Value-Based Partnerships at Amgen
Miami, Florida, United States11 -
2
-
ViewScott Doyle
Executive Director, Head of Specialty - Global HEOR at Astellas Pharma
London, England, United Kingdom21 -
34
-
11
-
ViewRichard Fisher
Director, Wilmot Cancer Center, University of Rochester at University of Rochester
New York, United States35+ -
21
-
View
Rodrigo Refoios Camejo
Executive Director, Head of Value Evidence, Research at GSK
London, England, GB35
Top Vaccibody AS Employees
-
5+5
-
11
-
ViewKresten Skak
Vice President, Head of in vitro and in vivo discovery at Vaccibody AS
Gentofte Municipality, DK54 -
5
-
4
-
41
-
2
-
ViewRoberto Oliveri
Head of Medical Translational Development at Vaccibody AS
Copenhagen, Capital Region, Denmark2 -
22
-
31
-
3
-
1
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups / month.
Search
Search over 700
million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers
(business & personal).
G2Crowd Trusted
300K+
Plugin Users
